orthofix
-
Biologics
Orthofix and MTF Biologics Expand Partnership Agreement
May 3, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthofix Announces New Business Unit President
Kimberley Elting, Chief Legal and Development Officer for Orthofix, Appointed to Lead Global Orthopedics Business April 8, 2022 LEWISVILLE, Texas–(BUSINESS…
Read More » -
Regulatory
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
Designed for complex limb reconstruction and deformity correction procedures, the system features radiolucent rings and struts for clearer visualization under…
Read More » -
Financial
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
Fourth quarter net sales of $125.1 million, an increase of 6% over the prior year2021 annual net sales of $464.5…
Read More » -
Biologics
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
September 21, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Extremities
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
September 1, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Financial
Orthofix Reports Second Quarter 2021 Results
Net sales of $121 million, up 66% compared to prior year and 5% compared to the second quarter of 2019U.S.…
Read More »